Crezet

Crezet
Product Description

1) Indication :  Treatment of primary hypercholesterolemia or to decrease elevated fat level in blood (mixed hyperlipidemia) in adult patients 
2) Composition : Ezetimibe, Rosuvastain calcium (strength: 10/20mg, 10/10mg,10/5mg)
3) Dosage & Administration : Once a day with or without meal 
4) Development Plan :  Completed Clinical Phase III in Korea

We are actively seeking an overseas partner who is interested to run clinical development , registering and commercializing Crezet outside Korea.

Daewoong Pharmaceutical Co.,Ltd

  • KR
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Specifications
  • Selling Points
    Cardiovascular Health
  • Model
    Fixed Dose Combination
  • Supplied from
    Korea, Republic of

Daewoong Pharmaceutical Co.,Ltd

  • KR
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from Daewoong Pharmaceutical Co.,Ltd (4)

  • NABOTA

    Product NABOTA

    Botulinum toxin type A

    Indication: Glabella Lines (Approved in KR, US, Canada, on-going registration in EU), 
    Post Stroke Upper Limb Spasticity (Approved in KR), 
    Crow's feet (Approved in KR), Blepharospasm (Approved in KR)

    - NabotaTM is the only 900kDa neurotoxi...
  • Enavogliflozin (SGLT2i)

    Product Enavogliflozin (SGLT2i)

    Enavogliflozin is a best-in-class SGLT2 inhibitor for T2DM.


    Highlights of Enavogliflozin:
    * NDA filed, Accelerated Approval granted by MFDS, expected market approval within 2022 for T2DM
    * T2DM Phase III was completed in Korea as a stand-alone and as combinations with other anti...
  • Epodion

    Product Epodion

    2000, 3000, 4000, 10000IU / Pre-filled syringe Inj.

    Albumin-FREE
    rhEPO (recombinant human erythropoietin)

    Indication:
    Anemia in chronic renal failure

    - EpodionTM is PFS type of Erytrhopoietin - alpha (rhEPO) for improving the hemoglobin and hematocrit level ...
  • Eposis

    Product Eposis

    2000, 3000, 4000, 5000, 6000, 8000, 10000IU / Pre-filled syringe Inj.

    rhEPO (recombinant human erythropoietin)

    Indication:
    Anemia in chronic renal failure

    - EposisTM demonstrated significant improvement and safety for patients with anemia in Chronic Renal Failure (CRF).
    ...

Daewoong Pharmaceutical Co.,Ltd resources (2)

  • News Daewoong Pharm’s COVID-19 cure enters Phase 2 trial in Mexico

    An investigator-initiated Phase 2 clinical trial of Daewoong Pharm’s COVID-19 drug candidate has been kicked off at several health centers in Mexico, including Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. The sponsor-investigator study will evaluate the efficacy and safety profile of Foistar Tab. (camostat mesylate) in 180 COVID-19 patients with mild to moderate ...